new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Roche Palo Alto Llc
Roche Palo Alto Llc_20100107
Roche Palo Alto Llc_20100128
Roche Palo Alto Llc_20100121
  

Roche Palo Alto Llc patents

Recent patent applications related to Roche Palo Alto Llc. Roche Palo Alto Llc is listed as an Agent/Assignee. Note: Roche Palo Alto Llc may have other listings under different names/spellings. We're not affiliated with Roche Palo Alto Llc, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "R" | Roche Palo Alto Llc-related inventors




Date Roche Palo Alto Llc patents (updated weekly) - BOOKMARK this page
03/23/17 new patent  Thiadiazole-substituted arylamides as p2x3 and p2x2/3 antagonists
03/02/17Substituted pyridines as p2x3 and p2x2/3 antagonists
03/02/17Biphenyl and phenyl-pyridine amides as p2x3 and p2x2/3 antagonists
12/15/16Indole, indazole and benzimidazole arylamides as p2x3 and p2x2/3 antagonists
09/22/16Methods of using diaminopyrimidine p2x3 and p2x2/3 receptor modulators for treatment of respiratory and gastrointestinal diseases
08/04/16Thiazole and oxazole-substituted arylamides as p2x3 and p2x2/3 antagonists
07/21/16Pyrazolo[1,5a]pyrimidine derivatives as irak4 modulators
01/07/16Liquid pharmaceutical formulations of palonosetron
10/29/15Liquid pharmaceutical formulations of palonosetron
09/24/15Tetralin and indane derivatives and uses thereof
05/21/15Liquid pharmaceutical formulations of palonosetron
03/19/15Pyridinyl amides as p2x3 and p2x2/3 inhibitors
03/05/15Tetrazole-substituted arylamides as p2x3 and p2x2/3 antagonists
03/05/15Triazole-substituted arylamides as p2x3 and p2x2/3 modulators
12/04/14Diaminopyrimidines as p2x3 and p2x2/3 antagonists
10/30/14Oxazolone and pyrrolidinone-substituted arylamides as p2x3 and p2x2/3 antagonists
07/10/14Inhibitors of bruton's tyrosine kinase
02/13/14Process for synthesis of phenoxy diaminopyrimidine derivatives
09/12/134'-substituted nucleoside derivatives as inhibitors of hcv rna replication
08/29/13Methods of using diaminopyrimidine p2x3 and p2x2/3 receptor modulators for treatment of respiratory and gastrointestinal diseases
08/15/13Heterocyclic antiviral compounds
08/01/13Antibodies against human il17 and uses thereof
05/16/13Benzoxazine derivatives and uses thereof
05/17/12Methods of using diaminopyrimidine as p2x3 and p2x2/3 receptor modulators for treatment of respiratory and gastrointestinal diseases
04/12/12Tetralin and indane derivatives and uses thereof
01/19/12Tetrazole-substituted arylamides as p2x3 and p2x2/3 antagonists
01/12/12Heterocyclic antiviral compounds
12/29/11Process for synthesis of tritiated and deuterated thiorphan and acetorphan
12/08/11Heterocyclic antiviral compounds
11/03/11Process for synthesis of phenoxy diaminopyrimidine derivatives
10/06/11Triazole-substituted arylamides as p2x3 and p2x2/3 antagonists
09/29/11Imidazolinylmethyl aryl sulfonamide
09/29/11Substituted pyrazoles, compositions containing these, production and use
09/22/11Imidazolinylmethyl aryl sulfonamide
08/11/11Liquid pharmaceutical formulations of palonosetron
05/26/11Heterocyclic antiviral compounds
05/26/11Heterocyclic antiviral compounds
03/31/11Diaminopyrimidines as p2x3 and p2x2/3 antagonists
03/24/11Heterocyclic antiviral compounds
07/08/10Hcv ns3 protease replicon shuttle vectors
07/01/10Anti-ox40l antibodies
03/04/10Inhibitors of hiv-1 reverse transcriptase
02/18/10Salicylamide derivatives as nicotinic alpha 7 modulators
02/04/10Phosphodiesterase 4 inhibitors
01/28/10Heterocyclic antiviral compounds
01/21/10Inhibitors of bruton's tyrosine kinase
01/21/10Inhibitors of bruton's tyrosine kinase
01/21/10Substituted indolyl and indazolyl derivatives and uses thereof
01/07/10Inhibitors of burton's tyrosine kinase
12/31/09Benzoxazine derivatives and uses thereof
12/31/09Thienyl-and furanyl-isoquinolinones and methods for using them
12/24/09Inhibitors of bruton's tyrosine kinase
12/24/09Inhibitors of jnk
12/24/09Aryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof
12/10/09Inhibitors of bruton's tyrosine kinase
11/26/09Insulinotropic peptide synthesis using solid and solution phase combination techniques
11/12/09Heterocyclic antiviral compounds
11/05/09New ruthenium complexes as catalysts for metathesis reactions
10/29/09Pyrimidinyl pyridone inhibitors of kinases
09/10/09Afucosylated antibodies against ccr5 and their use for the treatment of inflammatory conditions
09/03/09Process for preparing concentrated aqueous micellar solutions
08/20/09Heterocyclic antiviral compounds
08/20/09Pharmaceutical formulation of an antibody against il-1r
08/20/09Prediction of bone marrow toxicity
08/20/09Nucleoside prodrugs and uses thereof
Patent Packs
08/20/09Arylpiperazine derivatives and uses thereof
07/23/09Inhibitors of bruton's tyrosine kinase
07/09/09Polymorphic forms of oseltamivir phosphate
07/02/09Pyrazole-substituted arylamides as p2x3 and p2x2/3 antagonists
07/02/09Triazole-substituted arylamides as p2x3 and p2x2/3 antagonists
06/25/09Imidazole-substituted arylamides as p2x3 and p2x2/3 antagonists
06/25/09Tetrazole-substituted arylamides as p2x3 and p2x2/3 antagonists
06/25/09Process for the preparation of a macrocycle
06/11/09Ns5a nucleotide sequence variation as a marker for interferon response
06/04/09Peptide-complement conjugates
06/04/09Preparation of dihydropyrrol derivatives as intermediates
04/30/09Preparation of cyclopropyl sulfonylamides
04/23/09Btk protein kinase inhibitors
04/16/093-amino-1-arylpropyl indoles and aza-substituted indoles and uses thereof
04/16/09Methods of treating inflammatory diseases
Patent Packs
04/09/09Heterocyclic antiviral compounds
04/09/09Tetrazole-substituted aryl amide derivatives and uses thereof
04/09/09Cyclopropyl aryl amide derivatives and uses thereof
03/26/09Methods of treating genitourinary disorders using inhibitors of soluble epoxide hydrolase
03/19/09Non-nucleoside reverse transcriptase inhibitors
03/19/09Preparation of oseltamivir phosphate
01/28/10Heterocyclic antiviral compounds
01/21/10Substituted indolyl and indazolyl derivatives and uses thereof
01/07/10Inhibitors of burton's tyrosine kinase







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Roche Palo Alto Llc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Roche Palo Alto Llc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';